subject area of
- A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer Journal Articles
- A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies Journal Articles
- A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer Journal Articles
- Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin–Topotecan and Carboplatin–Paclitaxel vs Carboplatin–Paclitaxel Journal Articles
- Chemotherapy for Relapsed Small Cell Lung Cancer: A Systematic Review and Practice Guideline Journal Articles
- Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues Journal Articles
- Phase I Study of Combination Topotecan and Carboplatin in Pediatric Solid Tumors Journal Articles
- Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study Journal Articles
- Phase II Study of Sequential Topotecan and Etoposide in Patients with Intermediate Grade Non-Hodgkin's Lymphoma: A National Cancer Institute of Canada Clinical Trials Group Study Journal Articles
- Treatment with topotecan plus cyclophosphamide in children with first relapse of neuroblastoma Journal Articles
- UCN-01 in combination with topotecan in patients with advanced recurrent ovarian cancer: A study of the Princess Margaret Hospital Phase II consortium Journal Articles